Posts Tagged ‘FDA clearance’
Click Therapeutics raises further $52M to build up digital therapeutics pipeline for depression, insomnia, smoking cessation and more
With Sanofi still on board, Click Therapeutics closes $52M series B for digital therapeutics in depression, chronic pain and more (Fierce Biotech): Another medtech developer’s plans to create digital therapeutics to treat a wide range of illnesses are clicking into place, thanks to a third multimillion-dollar investment in Click Therapeutics in barely a year.
Read MoreWill digital therapeutics complement or replace stimulant medications to address inattention and “silent” cognitive issues?
___ Akili Interactive: Digital pediatric ADHD therapeutic performs well with or without accompanying stimulant therapy (MobiHealth News): “Digital therapeutic company Akili Interactive has announced the first results of an open-label, multisite pediatric ADHD trial providing some patients with the company’s video game-like treatment alongside a stimulant medication. According to the company, both those who received…
Read MoreLarge multi-center study to test videogame-like digital therapy as (potentially) FDA-cleared ADHD treatment
Akili Labs recruits for ADHD trial with ambitions of FDA clearance for digital medicine (MedCity News) “Akili Labs has kicked off open enrollment for a clinical trial of its Project EVO video game platform in a quest to secure for 510(k) clearance from the U.S. Food and Drug Administration for its lead indication
Read MoreAnthroTronix CEO Corinna Lathan to discuss 510(k) FDA clearance of its DANA neurocognitive test at 2014 SharpBrains Virtual Summit
Happy to share that Dr. Lathan, CEO of AnthroTronix, will discuss the brand-new 510(k) FDA clearance of their DANA neurocognitive test at the 2014 SharpBrains Virtual Summit (October 28–30th), during the session Best practices to assess and enhance brain function via mobile devices and wearables. Dr. Corinna Lathan leads AnthroTronix, a biomedical engineering product development company and…
Read More